Key result
Preoperative IV prostaglandin E1 substantially lowers PAP and reverses shunting to enable ASD closure.
Why the study?
Treating patients older than 50 years with ASD, excessively increased pulmonary artery pressure, and reversed shunting is controversial because surgical closure risks postoperative right heart failure. A beneficial effect of preoperative prostaglandin E1 in patients with reversed shunting before ASD surgery had not yet been investigated.
Does preoperative continuous intravenous prostaglandin E1 infusion reduce pulmonary artery pressure and reverse right-to-left shunting enough to allow safe surgical closure in an older patient with secundum ASD and severe pulmonary hypertension?
Case Report (n=1)
No
Does preoperative continuous intravenous prostaglandin E1 infusion reduce pulmonary artery pressure and reverse right-to-left shunting enough to allow safe surgical closure in an older patient with secundum ASD and severe pulmonary hypertension?
Preoperative intravenous PGE1 infusion can assess the reversibility of severe pulmonary hypertension and reverse right-to-left shunting in late-diagnosed adult ASD, successfully bridging otherwise inoperable patients to safe surgical repair.
Answers are grounded in this paper and cite their sources.
May support preoperative PGE1 to reverse shunting before ASD repair in severe PH; leaves open generalizability beyond this case report.
Atrial septal defects (ASD) are frequently diagnosed in adult patients [1-3], and surgical closure remains the therapy of choice [4,5]. However, the treatment of patients older than 50 years with excessively increased pulmonary artery pressure (PAP) and ASD is still controversial [6]. When reversed shunting (right to left atrium) is found, surgical closure of the ASD may lead to postoperative right heart failure due to pulmonary hypertension, and it is not considered a therapeutic choice [7,8]. Recently, prostaglandin E1 (PGE1) has been successfully introduced in the therapeutic management of heart transplantations [9], congenital heart disease [10], and patients with primary pulmonary hypertension. PGE1 markedly reduces PAP and pulmonary vascular resistance (PVR) due to a long-lasting vasodilatory effect [9]. However, a beneficial effect of PGE1 in patients with reversed shunting before ASD surgery has not yet been investigated. We present a patient with a secundum ASD, markedly increased PAP, and predominant right-to-left shunting in whom PGE1 was used in conjunction with diuresis and inotropic drugs to stabilize hemodynamic function before surgical closure. Case Report A 71-yr-old, 64-kg woman was referred to a regional hospital presenting with severe dyspnea, cyanosis, palpitation, peripheral edema, and hepatomegaly, meeting the criteria for New York Heart Association class IV. After initial cardiopulmonary stabilization, transesophageal echocardiography and right heart catheterization were performed. A secundum ASD was diagnosed with predominantly reversed shunting of 37% (Table 1) and a PAP of 104/44/60 mm Hg (PVR 408 dynes [center dot] s [center dot] cm-5; Table 2). The left ventricular ejection fraction (EF; 65%) was within normal range, but marked right heart dilation and severe tricuspid valve regurgitation were diagnosed. The patient was breathing room air, the hemoglobin concentration was 16.8 g/dL, and no sedation was given at that time.Table 1: Oxygen Saturation and Shunting Calculated by the Fick MethodTable 2: Hemodynamic ParametersBecause of these unfavorable hemodynamic conditions, success of surgery was considered unlikely, and preoperative therapy with PGE1 was initiated for acute pulmonary vasodilation. PGE1 was administered iv by continuous infusion for 10 days. The initial dose of 2 ng [center dot] kg-1 [center dot] min-1 was increased every 3 h by increments of 2 ng [center dot] kg-1 [center dot] min-1 until the maintenance dose of 16 ng [center dot] kg-1 [center dot] min-1 was achieved [9]. The patient was monitored for the entire infusion period with a pulmonary artery catheter, electrocardiogram, noninvasive arterial blood pressure, and pulse oximetry [11]. During therapy, the side effects of hypotension, reflex tachycardia, headache, swelling of the fingers, and arthralgia appeared to a moderate extent [12]. These symptoms were treated with small-dose catecholamines (dopamine 3.2 ng [center dot] kg-1 [center dot] min-1 for 6 days preoperatively), diuretics, and analgesics and disappeared soon after. Right heart catheterization was repeated twice (days 3 and 7 of PGE1 therapy; Table 1), and the hemodynamic monitoring was continued throughout the entire treatment period. After 7 days, PAP decreased to 42/19/26 mm Hg and PVR decreased to 200 dynes [center dot] s [center dot] cm-5 (Table 2). Reversed shunting disappeared completely, and left-to-right shunting increased to 71% (Table 1). Because of the improved hemodynamic conditions, a primary surgical closure was considered feasible. Under general anesthesia with etomidate, fentanyl, pancuronium, and isoflurane, median sternotomy was performed. The opening of the pericardium revealed a severely dilated right atrium and right ventricle. Extracorporeal circulation was initiated, and the right atrium was opened. A 3 x 2-cm secundum ASD was identified and directly closed using a running suture. After weaning from cardiopulmonary bypass, PAP decreased immediately to 21/5/16 mm Hg. The remaining surgery was uneventful, and there were no postoperative complications. The patient was tracheally extubated 8 h after surgery and did not require inotropic or chronotropic drug therapy. On the fourth postoperative day, catheterization was repeated, showing pulmonary hemodynamic parameters to be within normal range (Table 2). Transthoracic echocardiography showed no residual atrial defect, normal left ventricular function (EF 70%), an unchanged right heart chamber size, and moderately decreased tricuspid valve regurgitation. After 14 days, the patient was discharged on oral digoxin and diuretic therapy. During the following 3-mo period, the patient recovered quickly and regained cardiopulmonary performance appropriate for her age (New York Heart Association class II). At that time, right heart catheterization showed persistence of reduced values for PAP and PVR (Table 2). Discussion The surgical correction of symptomatic ASD in adults has been a matter of controversy [6-8]. Although surgical ASD closure is beneficial for young adults, the best treatment for older patients with increased PAP and reversed shunting is still undecided [13,14]. Cyanosis due to right-to-left shunting and excessive PAP occurs in only approximately 13% of all secundum ASD [15]. Reversed shunting is associated with greater surgical risk because of possible right ventricular failure due to irreversible pulmonary hypertension in the immediate postoperative period [16]. Nevertheless, our experience suggests that some patients with right-to-left shunting may be suitable for surgery. To identify these patients preoperatively, the reversibility of increased PAP or PVR can be tested with PGE1 administered iv for 10 days before surgery [9]. If PAP can be successfully decreased and the shunt flow can be reversed to a left-to-right direction, the technically easy surgical closure of the ASD can be safely performed. PGE1 is a monoenoic prostaglandin derived from dihomo-y-linolenic acid, which is normally present in the human body [9]. The main effects are a direct pulmonary vasodilation, inhibition of platelet aggregation, cytoprotection, and contribution to immunosuppression [9]. PGE1 is 70%-95% inactivated after a single passage through the pulmonary circulation [17]. PGE1 therapy is widely established for the treatment of primary or secondary pulmonary hypertension due to mitral stenosis, chronic obstructive pulmonary disease, or adult respiratory distress syndrome [18]. It is also used in infants to delay closure of a patent ductus arteriosus [10] and after heart transplant to reduce the frequency of rejection [18]. Furthermore, patients who are on a waiting list for heart transplant may benefit from a long-lasting decrease of PAP and PVR by PGE1[9]. In addition to those established indications, a beneficial effect of PGE1 before ASD closure in patients with Eisenmenger's syndrome is suggested by this report. Alternatively, nonspecific vasodilators such as nitroglycerin, nitroprusside, enoximone, and dobutamine have been reported to reduce PAP, but none of these seem to be as effective as PGE1[18]. Inhaled nitric oxide (NO) is a very selective pulmonary vasodilator, which has been used successfully to treat pulmonary hypertension in infants with congenital heart disease [19] and in some adult patients with acute respiratory distress syndrome [20]. However, the administration of NO is generally restricted to acute care units because it is best applied in conjunction with ventilatory support, and environmental safety precautions are also a concern. In contrast to this mainly intra- and postoperative application of NO, patient assessment and therapy with PGE (1) can be performed preoperatively without the inconvenience of immobilization. In conclusion, patients with late diagnosed congenital heart anomalies associated with Eisenmenger's syndrome (increased PVR and reversed shunting) can be evaluated with a PGE1 infusion to assess the reversibility of PVR and shunt and the feasibility of surgical repair.
No takes yet. Share an insight, caveat, or question.
Trantina et al. (1998) conducted a case report in Secundum atrial septal defect with markedly increased pulmonary artery pressure and predominant right-to-left shunting (n=1). Preoperative intravenous prostaglandin E1 (PGE1) followed by surgical ASD closure was evaluated on Pulmonary artery pressure (PAP), pulmonary vascular resistance (PVR), shunting direction, and feasibility of surgical ASD closure. Preoperative IV prostaglandin E1 for 7 days reduced PAP from 104/44/60 to 42/19/26 mm Hg and eliminated right-to-left shunting, enabling successful surgical ASD closure.
Synapse has enriched 10 related papers. Consider them for comparative context: